SNTI Stock Price, Chart, Stats & News

Senti Biosciences, Inc.
Save
26.42M
Market cap
–
Current P/E
–
Forward P/E
SNTI chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | -14777.27% |
Operating margin | -289668.18% |
Pretax margin | -279263.64% |
Net margin | -279263.64% |
Effective tax rate | – |
ROA | -119.94% |
ROE | -322.42% |
D/E | 5.17x |
Interest coverage ratio | – |
SNTI valuation
P/E | – |
P/S | 944.20x |
P/B | 3.18x |
P/CF | -0.41x |
P/FCF | -0.48x |
P/OCF | -0.41x |
PEG | 0.03x |
EV multiple | -0.14x |
About
Senti Biosciences, Inc. is a pioneering company specializing in gene circuit technology. They focus on creating advanced cell and gene therapies that incorporate sophisticated gene circuits, essentially biological computers, to genetically reprogram cells. This allows the modified cells to interpret biological cues, make precise decisions, and react appropriately within their specific cellular surroundings.
Similar securities
Based on sector and market capitalization
Report issue











